The U.S. Food and Drug Administration said Monday that companies making or hoping to sell so-called dynamic-stabilization systems for spinal surgery must run studies to collect data on “a number of potential safety issues.”
2nd UPDATE: FDA Orders Studies On Spinal Devices (NASDAQ)… http://ow.ly/sViS